May curb appetite and cravings, making portions easier to manage
Third, although existing studies consistently demonstrate beneficial effects on hepatic steatosis and inflammation, the lack of head-to-head mechanistic and biomarker-based comparisons restricts the ability to distinguish between different GLP-1RAs or combination therapies in terms of their molecular pathways, immunemetabolic regulatory efficiency, and predictive biomarkers of therapeutic response
Similarly, people with a history of psychiatric medications were 12% more likely to discontinue treatment within the first year, while those living with cardiovascular disease or other chronic conditions were around 10% more likely to stop treatment early -- also suggesting a higher likelihood of experiencing adverse effects
Retatrutide Phase 3 Results: What Patients Should Know Retatrutide gained more attention after the Phase 3 obesity trial results
10.1016/j.brainres.2015.12.052 207
Some individuals see results more quickly than others because of differences in their physical activity, diet, and metabolism